SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950144-07-002193
Filing Date
2007-03-14
Accepted
2007-03-14 17:29:59
Documents
8
Period of Report
2006-12-31

Document Format Files

Seq Description Document Type Size
1 BIOCRYST PHARMACEUTICALS, INC. g06036e10vk.htm 10-K 667574
2 EX-10.12 AMENDED AND RESTATED EMPLOYMENT LETTER AGREEMENT g06036exv10w12.htm EX-10.12 31102
3 EX-23 CONSENT OF ERNST & YOUNG g06036exv23.htm EX-23 3911
4 EX-31.1 SECTION 302 CERTIFICATION OF THE CEO g06036exv31w1.htm EX-31.1 8387
5 EX-31.2 SECTION 302 CERTIFICATION OF THE CFO g06036exv31w2.htm EX-31.2 8686
6 EX-32.1 SECTION 906 CERTIFICATION OF THE CEO g06036exv32w1.htm EX-32.1 2912
7 EX-32.2 SECTION 906 CERTIFICATION OF CFO g06036exv32w2.htm EX-32.2 2635
8 GRAPHIC g06036g0603601.gif GRAPHIC 8554
  Complete submission text file 0000950144-07-002193.txt   738558
Mailing Address 2190 PARKWAY LAKE DR BIRMINGHAM AL 35244
Business Address 2190 PARKWAY LAKE DR BIRMINGHAM AL 35244 2054444600
BIOCRYST PHARMACEUTICALS INC (Filer) CIK: 0000882796 (see all company filings)

IRS No.: 621413174 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-23186 | Film No.: 07694529
SIC: 2836 Biological Products, (No Diagnostic Substances)